Lacosamide vs Valproate for Partial-Onset Seizures

Efficacy and Safety Considerations

• The American Academy of Neurology suggests that valproate is classified as "probably effective" for treating partial-onset seizures based on Class II evidence 2
• Newer generation antiepileptic drugs like lacosamide are favored over older agents due to superior side effect profiles 3
• Lacosamide has minimal drug-drug interactions as a non-enzyme-inducing antiepileptic drug (NEIAED), making it safer when combined with other medications 3
• Valproate has significant teratogenicity risks and long-term impacts on bone health 3

Practical Clinical Application

• The American College of Neurology recommends initiating lacosamide at 100 mg/day with weekly titration in 100 mg/day increments to target dose of 200-400 mg/day, although the optimal dosing strategy is not explicitly stated in the provided citations 1
• Lacosamide is preferred in patients taking multiple concomitant medications where drug interactions are a concern 3
• In women of childbearing potential, lacosamide is preferred over valproate due to valproate's teratogenicity risks 3

Critical Pitfalls to Avoid

• Abrupt discontinuation of lacosamide can precipitate withdrawal seizures 1
• Lacosamide is not effective for prophylaxis in seizure-free patients, such as brain tumor patients without seizure history 3